Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Interest Expenses (2019 - 2025)

Biodesix's Interest Expenses history spans 7 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 17.52% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $7.7 million, down 6.55%, while the annual FY2025 figure was $7.7 million, 6.56% down from the prior year.
  • Interest Expenses reached $2.1 million in Q4 2025 per BDSX's latest filing, down from $2.1 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $3.0 million in Q3 2022 to a low of $651000.0 in Q1 2021.
  • Average Interest Expenses over 5 years is $1.9 million, with a median of $2.0 million recorded in 2024.
  • The largest YoY upside for Interest Expenses was 112.2% in 2021 against a maximum downside of 70.73% in 2021.
  • A 5-year view of Interest Expenses shows it stood at $1.5 million in 2021, then skyrocketed by 70.45% to $2.6 million in 2022, then fell by 8.67% to $2.3 million in 2023, then dropped by 24.77% to $1.8 million in 2024, then increased by 17.52% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Interest Expenses are $2.1 million (Q4 2025), $2.1 million (Q3 2025), and $1.9 million (Q2 2025).